-
Policymakers to identify groups of people who will get priority for COVID-19 vaccine
expresspharma
August 03, 2020
Four major challenges await India once a vaccine is available, i.e. prioritisation and fair distribution to vulnerable groups; logistics of vaccine rollout, including cold chain; stockpiling and training people who will administer this vaccine: ICMR Head.
-
Russia readying for mass vaccination against COVID-19 in October
expresspharma
August 03, 2020
Health Minister, Mikhail Murashko said doctors and teachers would be the first to be vaccinated.
-
GSK sees dip in second-quarter sales
pharmatimes
July 31, 2020
GlaxoSmithKline has reported group sales of £7.6 billion for the second quarter of 2020, marking a slip of 2% from a year ago, reflecting expected disruption from COVID-19.
-
IDT Biologika Fills SARS-CoV-2 Vaccine Candidate
contractpharma
July 30, 2020
IDT Biologika filled the second clinical batch of a newly-developed vaccine candidate against the coronavirus SARS-CoV-2 in Dessau.
-
Thermo Fisher Scientific Strengthens its Global Response to COVID-19 and continues to Support Development and Production of Therapeutics and Vaccines
expresspharma
July 30, 2020
Thermo Fisher Scientific, the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services network to support customers in government, industry and academia as they accelerate development and ...
-
Animal replacement method for vaccine testing developed by Intravacc and Leiden University
expresspharma
July 27, 2020
As a result of the Covid-19 pandemic, some 400 therapies and vaccines against this virus are currently being developed worldwide. This affects the number of laboratory animals used in studies.
-
EMA to monitor real world use of COVID-19 treatments and vaccines
europeanpharmaceuticalreview
July 24, 2020
The EMA has built up an infrastructure to allow for the monitoring of COVID-19 treatments and vaccines used in clinical practice.
-
China’s Sinopharm says coronavirus vaccine could be ready by year-end – state media
expresspharma
July 24, 2020
Sinopharm Chairman Liu Jingzhen told state broadcaster CCTV the company expects to finish late-stage human testing within about three months.
-
Promise and prevention: Experts discuss the race for a COVID-19 vaccine
expresspharma
July 24, 2020
As the global race for a COVID-19 vaccine heats up, Reuters invited a group of healthcare experts to answer questions as part of our #AskReuters Twitter chat series.
-
Wave of promising study results raises hopes for coronavirus vaccines
expresspharma
July 22, 2020
Whether any of these efforts will result in a vaccine capable of protecting billions of people and ending the global pandemic that has claimed more than 600,000 lives is still far from clear.